Federal Circuit Denies Re-Hearing for Cordis Corporation Patent Claims Against Medtronic, Inc., Abbott Laboratories, Boston Scientific Corporation
Published: Oct 16, 2013
The U.S. Court of Appeals for the Federal Circuit declines to revisit its decision to uphold a lower court's decision to invalidate patents for drug-eluting coronary stent technology. A federal appeals court last week declined to revisit its decision to uphold the invalidation of patents covering drug-eluting stent technology.
Help employers find you! Check out all the jobs and post your resume.